NHD Global
Healing & Tissue Repair · Source-reviewed dossier
Source-Reviewed Research Dossier
BPC-157 is a synthetic peptide studied mainly in cell and animal models of tissue repair. Researchers have examined cell movement, signaling and repair-related processes. A change in cultured cells does not by itself show faster recovery in people, and strong controlled human evidence remains limited. This page explains what the cited studies measured and lists the catalog identity and variants. Keep those findings separate from the records for any material supplied for a laboratory project.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A 2025 systematic review identified mainly animal and laboratory studies and highlighted the shortage of high-quality human evidence.
The review does not validate commercial BPC-157 products or administration practices.
Read the primary studyA 2025 literature and patent review summarized proposed gastrointestinal, vascular and tissue-repair actions.
Review-level synthesis and patents are not controlled clinical confirmation.
Read the primary studyResearchers isolated Achilles tendon fibroblasts from male Sprague-Dawley rats. BPC-157 increased growth-hormone-receptor expression, measured at mRNA and protein levels; subsequent growth-hormone stimulation increased proliferation-related measures.
This experiment studies a mechanism in rat cells. It does not measure recovery time, effectiveness or safety in human patients.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 2 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 20 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
The review does not validate commercial BPC-157 products or administration practices.
View primary recordReview-level synthesis and patents are not controlled clinical confirmation.
View primary recordThird-party publications selected for direct relevance.
Systematic review. 2025. PMID 40756949.
Literature and patent review. 2025. PMID 40005999.
Concise answers for researchers comparing identity, evidence and catalog variants.
In animal and laboratory models, BPC-157 has been studied for tissue-repair signaling, blood vessel formation, and reduced inflammatory markers. A 2025 systematic review found that orthopaedic research is almost entirely preclinical, with one small retrospective report of knee pain relief. These are model-bound findings, and they do not prove that the same effects occur in humans or that any clinical benefit exists.
The orthopaedic evidence base is mostly animal and cell studies, with one small retrospective human report and no controlled clinical safety data. Animal outcomes, narrative reports, and uncontrolled observations cannot establish human efficacy, dosing, or safety. Catalog identity and lot quality are separate from these research findings and are controlled by specifications and lot-specific documents.
The public literature is dominated by preclinical work and reviews; rigorous controlled human evidence remains insufficient.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
Tell us which records your project requires. Availability and scope must be confirmed for the selected material. Published papers are not batch certificates, and this page does not confirm that a lot-specific COA is available.
Request the storage conditions for the exact supplied form and selected variant. A temperature stated for another supplier or a clinical drug preparation is not a verified storage specification for NHD catalog material.
No. Migration means cells move; proliferation means cell numbers increase. Both can be studied in repair biology, but neither measurement alone establishes complete tissue repair or a human clinical benefit.
Send the exact product name, selected catalog variant, required quantity, destination and documents needed for the project. Specify whether the amount refers to powder mass or measured peptide content. Availability, price, lead time and document scope require confirmation.
No. A paper describes the material and methods used in that study. It does not establish the identity, purity or content of a different supplied lot. Ask which records actually apply to the requested material; do not assume a COA is available.
Knowledge center
Owned educational content connected to this family.
A source-led analysis of the 2026 BPC-157 and TB-500 rat Achilles tendon study, including group design, histology, biomechanics and the absence of an added…
Updated October 1, 2026
A critical review of the limited human evidence for BPC-157 and TB-500, current FDA-identified safety information gaps and the quality questions a research catalog…
Updated October 1, 2026
Cell movement and cell multiplication are different steps in tissue-repair research. This BPC-157 study measured both. The distinction matters because a positive cell result…
Updated October 9, 2026
A fair comparison starts before the first result. Learn how randomization, balanced handling and blinded assessment answer different experimental-design questions.
Updated October 10, 2026Source-traceable evidence
Structured readings of published studies, with the model, result and translation boundary stated explicitly.
A small rat study shows why “combined” does not automatically mean “better.”
Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: BC2 · 2 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
